Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of diet in multiple sclerosis.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
[Charcot and his legacy to medicine].
Abnormal Baseline Brain Activity in Patients with Multiple Sclerosis With Simple Spinal Cord Involvement Detected by Resting-State Functional Magnetic Resonance Imaging.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
The grey matter correlates of impaired decision-making in multiple sclerosis.
The induction of Treg cells by gut-indigenous Clostridium.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Fine-Tuning S1P Therapeutics.
Diverse functional roles of lipocalin-2 in the central nervous system.
The history of neuromyelitis optica.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »